Markus R Meyer - JoVE Visualize

Showing results (181-190 of 261) with videos related to

Pageof 27

Sort By:

Analytical and Bioanalytical Chemistry|November 9, 2011

Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n))Markus R Meyer, Julia Dinger, Andrea E Schwaninger, et al.

Drug Testing and Analysis|October 15, 2013

The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.)Markus R Meyer, Sandra Mauer, Golo M J Meyer, et al.

Journal of Analytical Toxicology|October 13, 2020

Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and BromazolamLea Wagmann, Sascha K Manier, Christina Felske, et al.

Drug Testing and Analysis|March 26, 2017

Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS<sup>n</sup> , and LC-HR-MS/MSAchim T Caspar, Jonas B Gaab, Julian A Michely, et al.

Therapeutic Drug Monitoring|February 17, 2007

Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency departmentMarc-A von Mach, Carola Weber, Markus R Meyer, et al.

Drug Testing and Analysis|February 19, 2016

Screening for illicit drugs in pooled human urine and urinated soil samples and studies on the stability of urinary excretion products of cocaine, MDMA, and MDEA in wastewater by hyphenated mass spectrometry techniquesMarie Mardal, Juliet Kinyua, Pedram Ramin, et al.

Toxicology Letters|May 8, 2020

Are pigs a suitable animal model for in vivo metabolism studies of new psychoactive substances? A comparison study using different in vitro/in vivo tools and U-47700 as model drugFrederike Nordmeier, Adrian Doerr, Matthias W Laschke, et al.

Metabolites|August 27, 2025

A Comparative Study Using Reversed-Phase and Hydrophilic Interaction Liquid Chromatography to Investigate the In Vitro and In Vivo Metabolism of Five Selenium-Containing Cathinone DerivativesLea Wagmann, Jana H Schmitt, Tanja M Gampfer, et al.

Biochemical Pharmacology|June 19, 2007

Biotechnological synthesis of drug metabolites using human cytochrome P450 2D6 heterologously expressed in fission yeast exemplified for the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinobutyrophenoneFrank T Peters, Calin-A Dragan, Désirée R Wilde, et al.

Journal of Analytical Toxicology|February 25, 2021

Systematic Studies on Temperature-Dependent In Vitro Stability during Storage and Smoking of the Synthetic Cannabinoid 5F-MDMB-P7AICANadja Walle, Adrian A Doerr, Matthias W Laschke, et al.

Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:

Pageof 27

Analytical and Bioanalytical Chemistry|November 9, 2011

Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n))Markus R Meyer, Julia Dinger, Andrea E Schwaninger, et al.

Drug Testing and Analysis|October 15, 2013

The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.)Markus R Meyer, Sandra Mauer, Golo M J Meyer, et al.

Journal of Analytical Toxicology|October 13, 2020

Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and BromazolamLea Wagmann, Sascha K Manier, Christina Felske, et al.

Drug Testing and Analysis|March 26, 2017

Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS<sup>n</sup> , and LC-HR-MS/MSAchim T Caspar, Jonas B Gaab, Julian A Michely, et al.

Therapeutic Drug Monitoring|February 17, 2007

Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency departmentMarc-A von Mach, Carola Weber, Markus R Meyer, et al.

Drug Testing and Analysis|February 19, 2016

Screening for illicit drugs in pooled human urine and urinated soil samples and studies on the stability of urinary excretion products of cocaine, MDMA, and MDEA in wastewater by hyphenated mass spectrometry techniquesMarie Mardal, Juliet Kinyua, Pedram Ramin, et al.

Toxicology Letters|May 8, 2020

Are pigs a suitable animal model for in vivo metabolism studies of new psychoactive substances? A comparison study using different in vitro/in vivo tools and U-47700 as model drugFrederike Nordmeier, Adrian Doerr, Matthias W Laschke, et al.

Metabolites|August 27, 2025

A Comparative Study Using Reversed-Phase and Hydrophilic Interaction Liquid Chromatography to Investigate the In Vitro and In Vivo Metabolism of Five Selenium-Containing Cathinone DerivativesLea Wagmann, Jana H Schmitt, Tanja M Gampfer, et al.

Biochemical Pharmacology|June 19, 2007

Biotechnological synthesis of drug metabolites using human cytochrome P450 2D6 heterologously expressed in fission yeast exemplified for the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinobutyrophenoneFrank T Peters, Calin-A Dragan, Désirée R Wilde, et al.

Journal of Analytical Toxicology|February 25, 2021

Systematic Studies on Temperature-Dependent In Vitro Stability during Storage and Smoking of the Synthetic Cannabinoid 5F-MDMB-P7AICANadja Walle, Adrian A Doerr, Matthias W Laschke, et al.

Pageof 27